Abstract
Critical care cardiology is a steadily and rapidly developing sub-specialization within cardiovascular medicine, since the first emergence of a coronary care unit in the early 1960s. Today, modern cardiac intensive care units (CICU) serve a complex patient population with a high burden of cardiovascular and non-cardiovascular critical illnesses. Treatment of these patients requires a multidisciplinary approach, with a combination of highly specialized knowledge and skills in cardiovascular diseases, as well as emergency, critical-care and internal medicine. The CICU has always posed special challenges to both experienced intensivists as well as fellows-in-training (FIT) and is certainly one of the most demanding training phases. In recent years, these challenges have grown significantly owing to technological innovations, with new and steadily rising numbers of complex interventional procedures and new options for temporary circulatory support for critically ill patients, such as venoarterial extracorporeal membrane oxygenation (VA-ECMO). Herein, we focus on the successful CICU management of these special patient cohorts, which must become an integral part of critical-care training.
Similar content being viewed by others
References
Morrow DA, Fang JC, Fintel DJ, Granger CB, Katz JN, Kushner FG, Kuvin JT, Lopez-Sendon J, McAreavey D, Nallamothu B, Page RL 2nd, Parrillo JE, Peterson PN, Winkelman C, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Clinical Cardiology, Council on Cardiovascular Nursing, and Council on Quality of Care and Outcomes Research (2012) Evolution of critical care cardiology: transformation of the cardiovascular intensive care unit and the emerging need for new medical staffing and training models: a scientific statement from the American Heart Association. Circulation 126:1408–1428. https://doi.org/10.1161/CIR.0b013e31826890b0
Katz JN, Minder M, Olenchock B, Price S, Goldfarb M, Washam JB, Barnett CF, Newby LK, van Diepen S (2016) The genesis, maturation, and future of critical care cardiology. J Am Coll Cardiol 68:67–79. https://doi.org/10.1016/j.jacc.2016.04.036
Fuster V (2018) The (R)Evolution of the CICU: better for the patient, better for education. J Am Coll Cardiol 72:2269–2271. https://doi.org/10.1016/j.jacc.2018.09.018
Kasaoka S (2017) Evolved role of the cardiovascular intensive care unit (CICU). J Intensive Care 22:72. https://doi.org/10.1186/s40560-017-0271-7
Lüsebrink E, Massberg S, Orban M (2020) Ten things ICU specialists need to know about new valvular procedures in interventional cardiology. Intensive Care Med 46:102–106. https://doi.org/10.1007/s00134-019-05824-6
Katz JN, Shah BR, Volz EM, Horton JR, Shaw LK, Newby LK, Granger CB, Mark DB, Califf RM, Becker RC (2010) Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomes. Crit Care Med 38:375–381. https://doi.org/10.1097/CCM.0b013e3181cb0a63
Schwerg M, Fulde F, Dreger H, Poller WC, Stangl K, Laule M (2016) Optimized implantation height of the Edwards SAPIEN 3 valve to minimize pacemaker implantation after TAVI. J Interv Cardiol 29:370–374. https://doi.org/10.1111/joic.12302
Spodick DH (2003) Acute cardiac tamponade. N Engl J Med 349:684–690. https://doi.org/10.1056/NEJMra022643
Stremmel C, Lüsebrink E, Massberg S, Orban M (2020) Treatment of acute pericardial tamponade with a high-vacuum drainage system. Clin Res Cardiol 109:263–265. https://doi.org/10.1007/s00392-019-01527-6
Stremmel C, Scherer C, Lüsebrink E, Kupka D, Schmid T, Stocker T, Kellnar A, Kleeberger J, Sinner MF, Petzold T, Mehilli J, Braun D, Orban M, Hausleiter J, Massberg S, Orban M (2021) Treatment of acute cardiac tamponade: a retrospective analysis of classical intermittent versus continuous pericardial drainage. Int J Cardiol Heart Vasc 32:100722. https://doi.org/10.1016/j.ijcha.2021.100722
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607. https://doi.org/10.1056/NEJMoa1008232
Lindman BR, Goldstein JS, Nassif ME, Zajarias A, Novak E, Tibrewala A, Vatterott AM, Lawler C, Damiano RJ, Moon MR, Lawton JS, Lasala JM, Maniar HS (2015) Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement. Heart 101:537–545. https://doi.org/10.1136/heartjnl-2014-307057
Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, Gutiérrez-Ibanes E, Munoz-Garcia AJ, Pan M, Webb JG, Herrmann HC, Kodali S, Nombela-Franco L, Tamburino C, Jilaihawi H, Masson JB, de Jr Brito FS, Ferreira MC, Lima VC, Mangione JA, Iung B, Vahanian A, Durand E, Tuzcu EM, Hayek SS, Angulo-Llanos R, Gómez-Doblas JJ, Castillo JC, Dvir D, Leon MB, Garcia E, Cobiella J, Vilacosta I, Barbanti M, Makkar R, Ribeiro HB, Urena M, Dumont E, Pibarot P, Lopez J, San Roman A, Rodés-Cabau J (2015) Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 131:1566–1574. https://doi.org/10.1161/CIRCULATIONAHA.114.014089
Cahill TJ, Prendergast BD (2016) Infective endocarditis. Lancet 387:882–893. https://doi.org/10.1016/S0140-6736(15)00067-7
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, ESC Scientific Document Group (2015) 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 36:3075–3128. https://doi.org/10.1093/eurheartj/ehv319
Hamm CW, Möllmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW, GARY-Executive Board (2014) The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 35:1588–1598. https://doi.org/10.1093/eurheartj/eht381
Ibrahim K, McCarthy CP, McCarthy KJ, Brown CH, Needham DM, Januzzi JL Jr, McEvoy JW (2018) Delirium in the cardiac intensive care unit. J Am Heart Assoc 7:e008568. https://doi.org/10.1161/JAHA.118.008568
Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R, American College of Critical Care Medicine (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41:263–306. https://doi.org/10.1097/CCM.0b013e3182783b72
Saia F, Martinez C, Gafoor S, Singh V, Ciuca C, Hofmann I, Marrozzini C, Tan J, Webb J, Sievert H, Marzocchi A, O’Neill WW (2015) Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv 8:681–688. https://doi.org/10.1016/j.jcin.2014.11.022
Scherer C, Lüsebrink E, Kupka D, Stocker TJ, Stark K, Stremmel C, Orban M, Petzold T, Germayer A, Mauthe K, Kääb S, Mehilli J, Braun D, Theiss H, Brunner S, Hausleiter J, Massberg S, Orban M (2020) Long-term clinical outcome of cardiogenic shock patients undergoing Impella CP treatment vs. standard of care. J Clin Med. 9:3803. https://doi.org/10.3390/jcm9123803
Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O’Neill W, Ornato JP, Stelling K, Thiele H, van Diepen S, Naidu SS (2019) SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 94:29–37. https://doi.org/10.1002/ccd.28329
Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S (2019) Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J 40:2671–2683. https://doi.org/10.1093/eurheartj/ehz363
Werdan K, Boeken U, Briegel MJ, Buerke M, Geppert A, Janssens U, Kelm M, Michels G, Pilarczyk K, Schlitt A, Thiele H, Willems S, Zeymer U, Zwißler B, Delle-Karth G, Ferrari M, Figulla H, Heller A, Hindricks G, Pichler-Cetin E, Pieske BM, Prondzinsky R, Thielmann M, Bauersachs J, Kopp I, Ruß M (2021) Kurzversion der 2. Auflage der deutsch-österreichischen S3-Leitlinie “Infarkt-bedingter Kardiogener Schock—diagnose, monitoring und therapie.” Anaesthesist. 70:42–70. https://doi.org/10.1007/s00101-020-00868-6
Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A (2014) Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry. Thromb Haemost 112:1190–1197. https://doi.org/10.1160/TH14-06-0489
Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U, CULPRIT-SHOCK Investigators (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377:2419–2432. https://doi.org/10.1056/NEJMoa1710261
Lascarrou JB, Merdji H, Le Gouge A, Colin G, Grillet G, Girardie P, Coupez E, Dequin PF, Cariou A, Boulain T, Brule N, Frat JP, Asfar P, Pichon N, Landais M, Plantefeve G, Quenot JP, Chakarian JC, Sirodot M, Legriel S, Letheulle J, Thevenin D, Desachy A, Delahaye A, Botoc V, Vimeux S, Martino F, Giraudeau B, Reignier J, CRICS-TRIGGERSEP Group (2019) Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med. 381:2327–2337. https://doi.org/10.1056/NEJMoa1906661
Nolan JP, Soar J, Cariou A, Cronberg T, Moulaert VR, Deakin CD, Bottiger BW, Friberg H, Sunde K, Sandroni C (2015) European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation 95:202–222. https://doi.org/10.1016/j.resuscitation.2015.07.018
Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T (2015) 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus statement on the use of percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol. 65:e7–e26. https://doi.org/10.1016/j.jacc.2015.03.036
Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, Gurley J, Nelson K, Malyala R, Panjrath GS, Zwischenberger JB, Pinney SP (2019) Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 73:698–716. https://doi.org/10.1016/j.jacc.2018.11.038
Brunner S, Guenther SPW, Lackermair K, Peterss S, Orban M, Boulesteix AL, Michel S, Hausleiter J, Massberg S, Hagl C (2019) Extracorporeal life support in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 73:2355–2357. https://doi.org/10.1016/j.jacc.2019.02.044
Lüsebrink E, Orban M, Kupka D, Scherer C, Hagl C, Zimmer S, Luedike P, Thiele H, Westermann D, Massberg S, Schäfer A, Orban M (2020) Prevention and treatment of pulmonary congestion in patients undergoing veno-arterial extracorporeal membrane oxygenation for cardiogenic shock. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa547
Keebler ME, Haddad EV, Choi CW, McGrane S, Zalawadiya S, Schlendorf KH, Brinkley DM, Danter MR, Wigger M, Menachem JN, Shah A, Lindenfeld J (2018) Venoarterial extracorporeal membrane oxygenation in cardiogenic shock. JACC Heart Fail 6:503–516. https://doi.org/10.1016/j.jchf.2017.11.017
Schmidt M, Pellegrino V, Combes A, Scheinkestel C, Cooper DJ, Hodgson C (2014) Mechanical ventilation during extracorporeal membrane oxygenation. Crit Care 18:203. https://doi.org/10.1186/cc13702
Napp LC, Brehm M, Kühn C, Schäfer A, Bauersachs J (2015) Heart against veno-arterial ECMO: competition visualized. Int J Cardiol 187:164–165. https://doi.org/10.1016/j.ijcard.2015.03.311
Wong JK, Smith TN, Pitcher HT, Hirose H, Cavarocchi NC (2012) Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation. Artif Organs 36:659–667. https://doi.org/10.1111/j.1525-1594.2012.01496.x
Lüsebrink E, Stremmel C, Stark K, Joskowiak D, Czermak T, Born F, Kupka D, Scherer C, Orban M, Petzold T, von Samson-Himmelstjerna P, Kääb S, Hagl C, Massberg S, Peterss S, Orban M (2020) Update on weaning from veno-arterial extracorporeal membrane oxygenation. J Clin Med 9:992. https://doi.org/10.3390/jcm9040992
Schäfer A, Werner N, Westenfeld R, Møller JE, Schulze PC, Karatolios K, Pappalardo F, Maly J, Staudacher D, Lebreton G, Delmas C, Hunziker P, Fritzenwanger M, Napp LC, Ferrari M, Tarantini G (2019) Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock—a European experienced users working group opinion. Int J Cardiol 291:96–104. https://doi.org/10.1016/j.ijcard.2019.05.044
Rougé A, Pelen F, Durand M, Schwebel C (2017) Argatroban for an alternative anticoagulant in HIT during ECMO. J Intensive Care 5:39. https://doi.org/10.1186/s40560-017-0235-y
Choi JH, Luc JGY, Weber MP, Reddy HG, Maynes EJ, Deb AK, Samuels LE, Morris RJ, Massey HT, Loforte A, Tchantchaleishvili V (2019) Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes. Ann Cardiothorac Surg 8:19–31. https://doi.org/10.21037/acs.2018.12.02
ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Extracorporeal Life Support Organization, Version 1.4 August 2017 Ann Arbor, www.elso.org
Freund A, Jobs A, Lurz P, Feistritzer HJ, de Waha-Thiele S, Meyer-Saraei R, Montalescot G, Huber K, Noc M, Windecker S, Zeymer U, Ouarrak T, Schneider S, Thiele H, Desch S (2020) Frequency and impact of bleeding on outcome in patients with cardiogenic shock. JACC Cardiovasc Interv 13:1182–1193. https://doi.org/10.1016/j.jcin.2020.02.042
Mazzeffi M, Greenwood J, Tanaka K, Menaker J, Rector R, Herr D, Kon Z, Lee J, Griffith B, Rajagopal K, Pham S (2016) Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg 101:682–689. https://doi.org/10.1016/j.athoracsur.2015.07.046
Boulate D, Luyt CE, Pozzi M, Niculescu M, Combes A, Leprince P, Kirsch M (2013) Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: an unrecognized problem. Eur J Cardiothorac Surg 44:544–549. https://doi.org/10.1093/ejcts/ezt125
Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, Colson P, Cudemus Deseda G, Dabboura S, Eckner D, Eden M, Eitel I, Frank D, Frey N, Funamoto M, Goßling A, Graf T, Hagl C, Kirchhof P, Kupka D, Landmesser U, Lipinski J, Lopes M, Majunke N, Maniuc O, McGrath D, Möbius-Winkler S, Morrow DA, Mourad M, Noel C, Nordbeck P, Orban M, Pappalardo F, Patel SM, Pauschinger M, Pazzanese V, Reichenspurner H, Sandri M, Schulze PC, Schwinger RHG, Sinning JM, Aksoy A, Skurk C, Szczanowicz L, Thiele H, Tietz F, Varshney A, Wechsler L, Westermann D (2020) Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study. Circulation 142:2095–2106. https://doi.org/10.1161/CIRCULATIONAHA.120.048792
Schrage B, Burkhoff D, Rübsamen N, Becher PM, Schwarzl M, Bernhardt A, Grahn H, Lubos E, Söffker G, Clemmensen P, Reichenspurner H, Blankenberg S, Westermann D (2018) Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock. JACC Heart Fail 6:1035–1043. https://doi.org/10.1016/j.jchf.2018.09.009
Lüsebrink E, Massberg S, Orban M (2021) The multiple options of left atrial and ventricular venting during veno-arterial extra-corporeal membrane oxygenation: practical considerations. Eur Heart J. 4:ehaa1073. https://doi.org/10.1093/eurheartj/ehaa1073
Banning AS, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K, Guagliumi G, Haine S, Kastrati A, Massberg S, Orban M, Myrmel T, Vuylsteke A, Alfonso F, Van de Werf F, Verheugt F, Flather M, Sabaté M, Vrints C, Gershlick AH, Collaborators (2021) (2020) Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial. EuroIntervention 16:e1227–e1236. https://doi.org/10.4244/EIJ-D-20-01076
Thiele H, Freund A, Gimenez MR, de Waha-Thiele S, Akin I, Pöss J, Feistritzer HJ, Fuernau G, Graf T, Nef H, Hamm C, Böhm M, Lauten A, Schulze PC, Voigt I, Nordbeck P, Felix SB, Abel P, Baldus S, Laufs U, Lenk K, Landmesser U, Skurk C, Pieske B, Tschöpe C, Hennersdorf M, Wengenmayer T, Preusch M, Maier LS, Jung C, Kelm M, Clemmensen P, Westermann D, Seidler T, Schieffer B, Rassaf T, Mahabadi AA, Vasa-Nicotera M, Meincke F, Seyfarth M, Kersten A, Rottbauer W, Boekstegers P, Muellenbach R, Dengler T, Kadel C, Schempf B, Karagiannidis C, Hopf HB, Lehmann R, Bufe A, Baumanns S, Öner A, Linke A, Sedding D, Ferrari M, Bruch L, Goldmann B, John S, Möllmann H, Franz J, Lapp H, Lauten P, Noc M, Goslar T, Oerlecke I, Ouarrak T, Schneider S, Desch S, Zeymer U, ECLS-SHOCK Investigators (2021) Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock—design and rationale of the ECLS-SHOCK trial. Am Heart J 234:1–11. https://doi.org/10.1016/j.ahj.2021.01.002
Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346(8):557–563. https://doi.org/10.1056/NEJMoa003289
Hypothermia after Cardiac Arrest Study Group (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549–556. https://doi.org/10.1056/NEJMoa012689
Kim F, Nichol G, Maynard C, Hallstrom A, Kudenchuk PJ, Rea T, Copass MK, Carlbom D, Deem S, Longstreth WT Jr, Olsufka M, Cobb LA (2014) Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial. JAMA 311:45–52. https://doi.org/10.1001/jama.2013.282173
Nordberg P, Taccone FS, Truhlar A, Forsberg S, Hollenberg J, Jonsson M, Cuny J, Goldstein P, Vermeersch N, Higuet A, Jiménes FC, Ortiz FR, Williams J, Desruelles D, Creteur J, Dillenbeck E, Busche C, Busch HJ, Ringh M, Konrad D, Peterson J, Vincent JL, Svensson L (2019) Effect of trans-nasal evaporative intra-arrest cooling on functional neurologic outcome in out-of-hospital cardiac arrest: the PRINCESS randomized clinical trial. JAMA 321:1677–1685. https://doi.org/10.1001/jama.2019.4149
Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Åneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Køber L, Langørgen J, Lilja G, Møller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H, TTM Trial Investigators (2013) Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 369:2197–2206. https://doi.org/10.1056/NEJMoa1310519
Lopez-de-Sa E, Juarez M, Armada E, Sanchez-Salado JC, Sanchez PL, Loma-Osorio P, Sionis A, Monedero MC, Martinez-Sellés M, Martín-Benitez JC, Ariza A, Uribarri A, Garcia-Acuña JM, Villa P, Perez PJ, Storm C, Dee A, Lopez-Sendon JL (2018) A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial. Intensive Care Med 44:1807–1815. https://doi.org/10.1007/s00134-018-5256-z
Kirkegaard H, Søreide E, de Haas I, Pettilä V, Taccone FS, Arus U, Storm C, Hassager C, Nielsen JF, Sørensen CA, Ilkjær S, Jeppesen AN, Grejs AM, Duez CHV, Hjort J, Larsen AI, Toome V, Tiainen M, Hästbacka J, Laitio T, Skrifvars MB (2017) Targeted temperature management for 48 vs 24 hours and neurologic outcome after out-of-hospital cardiac arrest: a randomized clinical trial. JAMA 318:341–350. https://doi.org/10.1001/jama.2017.8978
Funding
There was no funding for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Martin Orban has received speaker honoraria from Abbott Medical, AstraZeneca, Abiomed, Bayer vital, Biotronik, Bristol-Myers Squibb, CytoSorbents, Daiichi Sankyo Deutschland, Edwards Lifesciences Services, Sedana Medical, outside the submitted work. The other authors declare no conflict of interests.
Ethical standards
All ethical standards were met in writing and submitting this article.
Rights and permissions
About this article
Cite this article
Lüsebrink, E., Kellnar, A., Scherer, C. et al. New challenges in cardiac intensive care units. Clin Res Cardiol 110, 1369–1379 (2021). https://doi.org/10.1007/s00392-021-01869-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-021-01869-0